Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tokyo - Delayed Quote JPY

3-D Matrix, Ltd. (7777.T)

Compare
121.00
0.00
(0.00%)
At close: 3:30:00 PM GMT+9
Loading Chart for 7777.T
  • Previous Close 121.00
  • Open 123.00
  • Bid --
  • Ask --
  • Day's Range 120.00 - 124.00
  • 52 Week Range 97.00 - 190.00
  • Volume 600,900
  • Avg. Volume 2,285,313
  • Market Cap (intraday) 13.145B
  • Beta (5Y Monthly) 0.14
  • PE Ratio (TTM) --
  • EPS (TTM) -8.22
  • Earnings Date Jun 11, 2025 - Jun 16, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.

www.3d-matrix.co.jp

106

Full Time Employees

April 30

Fiscal Year Ends

Recent News: 7777.T

View More

Performance Overview: 7777.T

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

7777.T
26.67%
Nikkei 225 (^N225)
14.10%

1-Year Return

7777.T
0.82%
Nikkei 225 (^N225)
12.66%

3-Year Return

7777.T
67.39%
Nikkei 225 (^N225)
26.48%

5-Year Return

7777.T
62.42%
Nikkei 225 (^N225)
75.28%

Compare To: 7777.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7777.T

View More

Valuation Measures

Annual
As of 4/15/2025
  • Market Cap

    13.15B

  • Enterprise Value

    14.36B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.97

  • Price/Book (mrq)

    4.98

  • Enterprise Value/Revenue

    2.15

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -14.24%

  • Return on Assets (ttm)

    -10.78%

  • Return on Equity (ttm)

    -58.31%

  • Revenue (ttm)

    6.66B

  • Net Income Avi to Common (ttm)

    -949M

  • Diluted EPS (ttm)

    -8.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.98B

  • Total Debt/Equity (mrq)

    121.02%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 7777.T

View More

Company Insights: 7777.T

Research Reports: 7777.T

View More

People Also Watch